Increased Brownian Motion of Water Molecules in Livers With Advanced Fibrosis: Preclinical and Clinical Observations

Fan-Yi Xu1, Gen-Wen Hu2, Cun-Jing Zheng3

  • 1Department of Imaging and Interventional Radiology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.

Molecular Imaging
|July 2, 2026
PubMed

Insights

Apparent diffusion coefficient (ADC) may inaccurately reflect liver fibrosis due to T2 shine-through. Slow diffusion coefficient (SDC) offers a more reliable measure, showing increased SDC with advanced liver fibrosis in rat and human studies.

Area of Science:

  • Biomedical Imaging
  • Medical Physics
  • Hepatology

Background:

  • Liver fibrosis is characterized by increased water content, yet apparent diffusion coefficient (ADC) typically decreases.
  • This decrease is attributed to T2 shine-through, where prolonged T2 in fibrosis reduces signal decay between low and high b-value images.
  • Slow diffusion coefficient (SDC) is proposed to overcome T2 shine-through by focusing on Brownian motion.

Purpose of the Study:

  • To evaluate the utility of SDC in assessing liver fibrosis.
  • To compare ADC and SDC changes in induced liver fibrosis models in rats and human data.
  • To investigate the relationship between fibrosis stage and diffusion metrics.

Main Methods:

  • Calculated ADC and SDC in a rat model of liver fibrosis induced by biliary duct ligation (BDL).
  • Analyzed ADC and SDC from three human liver fibrosis datasets (male subjects only).
  • Correlated diffusion metrics with fibrosis progression over time (rats) and severity (humans).

Main Results:

  • Rat study: Liver ADC decreased stepwise post-BDL, while SDC increased stepwise.
  • Human studies: All three datasets showed lower ADC and higher SDC in advanced fibrosis compared to earlier stages.
  • Results consistently indicate SDC as a sensitive indicator of liver fibrosis progression.

Conclusions:

  • SDC is a more robust metric than ADC for evaluating liver fibrosis, unaffected by T2 shine-through.
  • Increased SDC correlates with the severity of liver fibrosis.
  • SDC holds potential as a non-invasive biomarker for liver fibrosis assessment.